Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma

被引:0
|
作者
Hernandez-Magana, Alexis [1 ]
Bensussen, Antonio [2 ]
Martinez-Garcia, Juan Carlos [2 ]
Alvarez-Buylla, Elena R. [1 ,3 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, Mexico
[2] Cinvestav IPN, Dept Control Automat, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Ctr Ciencias Complej C3, Mexico City, Mexico
关键词
hepatocellular carcinoma; cancer; rational design; cell plasticity; medical systems biology; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; FACTOR 4-ALPHA HNF4-ALPHA; CANCER STEM-CELLS; STELLATE CELLS; LIVER; PROMOTES; DEDIFFERENTIATION; TRANSCRIPTION; SENESCENCE;
D O I
10.3389/fmolb.2024.1404319
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The search for new therapeutic strategies against cancer has favored the emergence of rationally designed treatments. These treatments have focused on attacking cell plasticity mechanisms to block the transformation of epithelial cells into cancerous cells. The aim of these approaches was to control particularly lethal cancers such as hepatocellular carcinoma. However, they have not been able to control the progression of cancer for unknown reasons. Facing this scenario, emerging areas such as systems biology propose using engineering principles to design and optimize cancer treatments. Beyond the possibilities that this approach might offer, it is necessary to know whether its implementation at a clinical level is viable or not. Therefore, in this paper, we will review the engineering principles that could be applied to rationally design strategies against hepatocellular carcinoma, and discuss whether the necessary elements exist to implement them. In particular, we will emphasize whether these engineering principles could be applied to fight hepatocellular carcinoma.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma
    Yao, Min
    Wang, Li
    Yao, Yao
    Gu, Hong-Bing
    Yao, Deng-Fu
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (04) : 253 - 258
  • [22] Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma
    Amedei, Amedeo
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (05) : 527 - 529
  • [23] Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma
    Yao, Min
    Wang, Li
    Qiu, Liwei
    Qian, Qi
    Yao, Dengfu
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (04) : 453 - 460
  • [25] Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
    Sposito, Carlo
    Citterio, Davide
    Virdis, Matteo
    Battiston, Carlo
    Busset, Michele Droz Dit
    Flores, Maria
    Mazzaferro, Vincenzo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (34) : 4929 - 4942
  • [26] Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
    Yu Akazawa
    Toshihiro Suzuki
    Toshiaki Yoshikawa
    Shoichi Mizuno
    Yasunari Nakamoto
    Tetsuya Nakatsura
    [J]. World Journal of Meta-Analysis, 2019, 7 (03) : 80 - 95
  • [28] Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
    Luo, Yi
    Song, Lei
    Wang, Xinyu
    Huang, Yujie
    Liu, Yongqiang
    Wang, Qi
    Hong, Ming
    Yuan, Zhongyu
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [29] Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
    Ming-Cheng Guan
    Ming-Da Wang
    Si-Yu Liu
    Wei Ouyang
    Lei Liang
    Timothy M Pawlik
    Qiu-Ran Xu
    Dong-Sheng Huang
    Feng Shen
    Hong Zhu
    Tian Yang
    [J]. World Journal of Gastrointestinal Oncology, 2021, 13 (04) : 197 - 215
  • [30] Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
    Liu, Yu-Chin
    Yeh, Chau-Ting
    Lin, Kwang-Huei
    [J]. CELLS, 2020, 9 (06)